Wilson's disease
- PMID: 17276780
- DOI: 10.1016/S0140-6736(07)60196-2
Wilson's disease
Abstract
Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metabolism. Knowledge of the clinical presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterology and hepatology, neurology, psychiatry, and paediatrics. Wilson's disease invariably results in severe disability and death if untreated. The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder. Studies have identified the role of copper in disease pathogenesis and clinical, biochemical, and genetic markers that can be useful in diagnosis. There are several chelating agents and zinc salts for medical therapy. Liver transplantation corrects the underlying pathophysiology and can be lifesaving. The discovery of the Wilson's disease gene has opened up a new molecular diagnostic approach, and could form the basis of future gene therapy.
Comment in
-
Wilson's disease.Lancet. 2007 Mar 17;369(9565):902. doi: 10.1016/S0140-6736(07)60438-3. Lancet. 2007. PMID: 17368141 No abstract available.
-
Wilson's disease.Lancet. 2007 Mar 17;369(9565):902. doi: 10.1016/S0140-6736(07)60437-1. Lancet. 2007. PMID: 17368142 No abstract available.
-
Wilson's disease.Lancet. 2007 Mar 17;369(9565):902-3. doi: 10.1016/S0140-6736(07)60439-5. Lancet. 2007. PMID: 17368143 No abstract available.
Similar articles
-
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.J Clin Pharm Ther. 2007 Feb;32(1):101-7. doi: 10.1111/j.1365-2710.2007.00794.x. J Clin Pharm Ther. 2007. PMID: 17286794
-
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.Sci Prog. 2013;96(Pt 1):19-32. doi: 10.3184/003685013X13587771579987. Sci Prog. 2013. PMID: 23738435 Free PMC article. Review.
-
Clinical considerations for an effective medical therapy in Wilson's disease.Ann N Y Acad Sci. 2014 May;1315:81-5. doi: 10.1111/nyas.12437. Epub 2014 Apr 22. Ann N Y Acad Sci. 2014. PMID: 24754532 Review.
-
Practical recommendations and new therapies for Wilson's disease.Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004. Drugs. 1995. PMID: 8521757 Review.
-
Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.Dev Pharmacol Ther. 1992;19(1):6-9. doi: 10.1159/000457456. Dev Pharmacol Ther. 1992. PMID: 1307347
Cited by
-
Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.Orphanet J Rare Dis. 2024 Jul 9;19(1):261. doi: 10.1186/s13023-024-03271-1. Orphanet J Rare Dis. 2024. PMID: 38982450 Free PMC article.
-
PET with 64Cu-histidine for noninvasive diagnosis of biliary copper excretion in Long-Evans cinnamon rat model of Wilson disease.J Nucl Med. 2012 Jun;53(6):961-8. doi: 10.2967/jnumed.111.092361. Epub 2012 May 10. J Nucl Med. 2012. PMID: 22577234 Free PMC article.
-
Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum.Can J Gastroenterol. 2012 Jun;26(6):330-2. doi: 10.1155/2012/176543. Can J Gastroenterol. 2012. PMID: 22720273 Free PMC article.
-
Epidemiology of Wilson disease in Germany - real-world insights from a claims data study.Orphanet J Rare Dis. 2024 Sep 11;19(1):335. doi: 10.1186/s13023-024-03351-2. Orphanet J Rare Dis. 2024. PMID: 39261850 Free PMC article.
-
Pharmacological activity of metal binding agents that alter copper bioavailability.Dalton Trans. 2015 May 21;44(19):8760-70. doi: 10.1039/c5dt00634a. Dalton Trans. 2015. PMID: 25797044 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical